These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 11545770)
1. Association of eptifibatide and acute profound thrombocytopenia. Hongo RH; Brent BN Am J Cardiol; 2001 Aug; 88(4):428-31. PubMed ID: 11545770 [No Abstract] [Full Text] [Related]
2. Acute profound thrombocytopenia associated with readministration of eptifibatide: case report and review of the literature. Russell KN; Schnabel JG; Rochetto RP; Tanner MC Pharmacotherapy; 2009 Jul; 29(7):867-74. PubMed ID: 19558261 [TBL] [Abstract][Full Text] [Related]
3. Severe thrombocytopenia possibly related to readministration of eptifibatide. Paradiso-Hardy FL; Madan M; Radhakrishnan S; Hurden S; Cohen EA Catheter Cardiovasc Interv; 2001 Sep; 54(1):63-7. PubMed ID: 11553950 [TBL] [Abstract][Full Text] [Related]
4. Acute profound thrombocytopenia with second exposure to eptifibatide associated with a strong antibody reaction. Attaya S; Kanthi Y; Aster R; McCrae K Platelets; 2009 Feb; 20(1):64-7. PubMed ID: 19172524 [TBL] [Abstract][Full Text] [Related]
5. Reversible thrombocytopenia associated with eptifibatide. Yoder M; Edwards RF Ann Pharmacother; 2002 Apr; 36(4):628-30. PubMed ID: 11918511 [TBL] [Abstract][Full Text] [Related]
6. Acute profound thrombocytopenia associated with eptifibatide therapy. Nagge J; Jackevicius C; Dzavik V; Ross JR; Seidelin P Pharmacotherapy; 2003 Mar; 23(3):374-9. PubMed ID: 12627937 [TBL] [Abstract][Full Text] [Related]
7. Eptifibatide-induced thrombocytopenia. Refaat M; Smith AJ; Edmundowicz D J Thromb Thrombolysis; 2008 Apr; 25(2):204-6. PubMed ID: 18008040 [TBL] [Abstract][Full Text] [Related]
8. Thrombocytopenia associated with antithrombotic therapy in acute coronary syndrome. Ho R; Kayser SR Prog Cardiovasc Nurs; 2003; 18(4):198-200. PubMed ID: 14605523 [No Abstract] [Full Text] [Related]
9. Recurrent acute profound thrombocytopenia related to readministration of eptifibatide. Cheema AA; Teklinski AH; Maria V; Chilukuri K; Frank JJ; Gosselin MO J Interv Cardiol; 2006 Feb; 19(1):99-103. PubMed ID: 16483348 [TBL] [Abstract][Full Text] [Related]
10. Incidence and time course of thrombocytopenia with abciximab and eptifibatide in patients undergoing percutaneous coronary intervention. Fahdi IE; Saucedo JF; Hennebry T; Ghani M; Sadanandan S; Garza-Arreola L Am J Cardiol; 2004 Feb; 93(4):453-5. PubMed ID: 14969621 [TBL] [Abstract][Full Text] [Related]
11. Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty. Tempelhof MW; Benzuly KH; Fintel D; Krichavsky MZ Tex Heart Inst J; 2012; 39(1):86-91. PubMed ID: 22412237 [TBL] [Abstract][Full Text] [Related]